|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
PL2426143T3
(pl)
*
|
2007-01-05 |
2017-12-29 |
University Of Zurich |
Sposób zapewniania specyficznych wobec choroby cząsteczek wiążących i celów
|
|
CN101965365A
(zh)
*
|
2007-10-19 |
2011-02-02 |
伊缪纳斯制药株式会社 |
能够特异性结合Aβ寡聚体的抗体及其应用
|
|
PL2246427T3
(pl)
|
2008-02-08 |
2017-06-30 |
Immunas Pharma, Inc. |
Przeciwciała zdolne do wiązania się swoiście do oligomerów amyloidu beta i ich stosowanie
|
|
CA2730073A1
(en)
*
|
2008-07-09 |
2010-01-14 |
University Of Zurich |
Method of promoting neurogenesis
|
|
DK2370466T3
(en)
|
2008-12-19 |
2015-08-03 |
Univ Zuerich |
Humane anti-alpha-synuclein-autoantistoffer
|
|
JP5812418B2
(ja)
|
2009-04-17 |
2015-11-11 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
CN102596997B
(zh)
|
2009-08-06 |
2015-06-03 |
伊缪纳斯制药株式会社 |
特异性结合Aβ寡聚体的抗体及其用途
|
|
MY171234A
(en)
|
2010-02-24 |
2019-10-04 |
Immunogen Inc |
Folate receptor 1 antibodies and immunoconjugates and uses thereof
|
|
US20150018408A1
(en)
*
|
2013-07-10 |
2015-01-15 |
The Regents Of The University Of Michigan |
Therapeutic antibodies and uses thereof
|
|
CN105646709A
(zh)
|
2011-01-10 |
2016-06-08 |
密执安大学评议会 |
干细胞因子抑制剂
|
|
PT2663579T
(pt)
|
2011-01-14 |
2017-07-28 |
Univ California |
Terapêutica de anticorpos contra a proteína r0r-1 e métodos para sua utilização
|
|
EP3318273B1
(en)
*
|
2011-04-01 |
2019-08-21 |
ImmunoGen, Inc. |
Methods for increasing efficacy of folr1 cancer therapy
|
|
CA2839563C
(en)
|
2011-06-23 |
2019-10-29 |
Biogen Idec International Neuroscience Gmbh |
Anti-alpha synuclein binding molecules
|
|
GB201110938D0
(en)
*
|
2011-06-27 |
2011-08-10 |
Iti Scotland Ltd |
Compounds
|
|
EP2756002A4
(en)
*
|
2011-09-16 |
2015-04-08 |
Univ Texas |
COMPOSITIONS AND METHODS RELATED TO THE REPAIR OF DNA DAMAGES
|
|
HUE049693T2
(hu)
*
|
2012-08-31 |
2020-10-28 |
Immunogen Inc |
Diagnosztikai ASSAY-k és készletek a folát receptor 1 kimutatására
|
|
WO2014100439A2
(en)
|
2012-12-19 |
2014-06-26 |
Amplimmune, Inc. |
B7-h4 specific antibodies, and compositions and methods of use thereof
|
|
US9534044B2
(en)
*
|
2013-02-28 |
2017-01-03 |
United Arab Emirates University |
Alpha-synuclein antibodies and uses thereof
|
|
US9914775B2
(en)
*
|
2013-08-21 |
2018-03-13 |
The Board Of Regents Of The University Of Texas System |
Methods for treating inflammatory disorders or cancer metastasis by administering antibodies to connexin 43 (Cx43) hemichannels
|
|
LT3038650T
(lt)
|
2013-08-30 |
2021-09-10 |
Immunogen, Inc. |
Antikūnai ir foliatų receptoriaus 1 nustatymo testai
|
|
EP3054974A4
(en)
*
|
2013-10-10 |
2017-06-14 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
EP3062818B1
(en)
*
|
2013-11-01 |
2019-09-11 |
IBC Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
|
|
US20160356794A1
(en)
*
|
2014-02-10 |
2016-12-08 |
Merck Sharp & Dohme Corp. |
Antibodies that bind to human tau and assay for quantifying human tau using the antibodies
|
|
EP3119805A1
(en)
|
2014-03-20 |
2017-01-25 |
Wellstat Diagnostics, LLC |
Antibodies and methods for the detection of cell death
|
|
EP3129048B1
(en)
*
|
2014-04-10 |
2020-01-15 |
OBI Pharma Inc. |
Antibodies binding to tumour associated carbohydrate antigens, pharmaceutical compositions and uses thereof
|
|
EA036311B1
(ru)
|
2014-08-19 |
2020-10-26 |
Мерк Шарп И Доум Корп. |
Антитела против tigit
|
|
MX358243B
(es)
|
2014-09-16 |
2018-08-10 |
Ovascience Inc |
Anticuerpos anti-vasa y metodos de produccion y uso de los mismos.
|
|
WO2016061389A2
(en)
*
|
2014-10-16 |
2016-04-21 |
Genentech, Inc. |
Anti-alpha-synuclein antibodies and methods of use
|
|
EP3218005B1
(en)
|
2014-11-12 |
2023-01-04 |
Seagen Inc. |
Glycan-interacting compounds and methods of use
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
ES2870983T3
(es)
*
|
2014-12-19 |
2021-10-28 |
Univ Nantes |
Anticuerpos anti-IL-34
|
|
CN107531781B
(zh)
*
|
2015-01-29 |
2021-12-07 |
抗菌技术,生物技术研究与发展股份有限公司 |
用于阿尔茨海默病和相关紊乱的抗体分子和肽递送系统
|
|
EP3262070A4
(en)
*
|
2015-02-24 |
2018-07-25 |
Rpeptide, LLC |
Anti-amyloid-beta antibodies
|
|
US10517948B2
(en)
|
2015-03-11 |
2019-12-31 |
The Board Of Regents Of The University Of Texas System |
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
|
|
WO2016149116A1
(en)
*
|
2015-03-13 |
2016-09-22 |
University Of Maryland, Baltimore |
Antibodies targeting s100b and methods of use
|
|
AU2016243124A1
(en)
*
|
2015-03-27 |
2017-11-02 |
University Of Southern California |
CAR T-cell therapy directed to LHR for the treatment of solid tumors
|
|
CA2988912C
(en)
*
|
2015-06-10 |
2023-09-12 |
National Research Council Of Canada |
Carbonic anhydrase ix-specific antibodies and uses thereof
|
|
WO2016205566A1
(en)
*
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
AU2016307845B2
(en)
*
|
2015-08-14 |
2020-10-15 |
Merck Sharp & Dohme Llc |
Anti-TIGIT antibodies
|
|
CN108699145A
(zh)
|
2015-09-02 |
2018-10-23 |
伊缪泰普有限公司 |
抗lag-3抗体
|
|
KR102700777B1
(ko)
|
2015-09-17 |
2024-08-29 |
이뮤노젠 아이엔씨 |
항-folr1 면역접합체를 포함하는 치료제 조합
|
|
WO2017079835A1
(en)
|
2015-11-09 |
2017-05-18 |
The University Of British Columbia |
Amyloid beta epitopes and antibodies thereto
|
|
JP7065516B2
(ja)
|
2015-11-09 |
2022-05-12 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
アミロイドベータのｎ末端エピトープおよびそれに対する立体配座選択的抗体
|
|
JP7448174B2
(ja)
|
2015-11-09 |
2024-03-12 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
アミロイドベータ中間領域エピトープおよびそれに対する立体配座選択的抗体
|
|
WO2017083582A1
(en)
|
2015-11-12 |
2017-05-18 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
TW202409084A
(zh)
|
2016-03-04 |
2024-03-01 |
美商Ｊｎ生物科學有限責任公司 |
針對tigit之抗體
|
|
KR102477922B1
(ko)
*
|
2016-03-16 |
2022-12-14 |
아베오미 코포레이션 |
Il-25에 대한 중화 모노클로날 항체 및 그의 용도
|
|
US20180362660A1
(en)
*
|
2016-05-09 |
2018-12-20 |
Schickwann Tsai |
Anti-penumbra monoclonal antibodies for detection and therapy of normal and abnormal B lymphocytes
|
|
RU2019100102A
(ru)
|
2016-06-16 |
2020-07-16 |
Дзе Борд Оф Трастиз Оф Дзе Лелэнд Стэнфорд Джуниор Юниверсити |
Гуманизированные и химерные моноклональные антитела против cd81
|
|
KR102550991B1
(ko)
*
|
2016-07-18 |
2023-07-04 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타에 대한 항체
|
|
JOP20170154B1
(ar)
*
|
2016-08-01 |
2023-03-28 |
Omeros Corp |
تركيبات وطرق لتثبيط masp-3 لعلاج أمراض واضطرابات مختلفة
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
US11401330B2
(en)
|
2016-11-17 |
2022-08-02 |
Seagen Inc. |
Glycan-interacting compounds and methods of use
|
|
US10899842B2
(en)
|
2016-11-23 |
2021-01-26 |
Immunoah Therapeutics, Inc. |
4-1BB binding proteins and uses thereof
|
|
CN106749657A
(zh)
*
|
2016-12-13 |
2017-05-31 |
中国农业科学院哈尔滨兽医研究所 |
一种抗体信号肽及其应用
|
|
WO2018156434A1
(en)
*
|
2017-02-22 |
2018-08-30 |
H. Lee Moffitt Cancer Center And Research Institute Inc. |
Tim3-binding chimeric antigen receptors
|
|
WO2018158398A1
(en)
*
|
2017-03-02 |
2018-09-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to nectin-4 and uses thereof
|
|
CA3054939A1
(en)
|
2017-03-03 |
2018-09-07 |
Seattle Genetics, Inc. |
Glycan-interacting compounds and methods of use
|
|
EP3608335A4
(en)
*
|
2017-04-05 |
2020-04-29 |
XDCExplorer (Shanghai) Co., Ltd. |
HUMANIZED ANTI-TPBG ANTIBODY, PRODUCTION METHOD THEREFOR, CONJUGATE THEREOF AND APPLICATIONS
|
|
MA49652A
(fr)
|
2017-07-17 |
2020-05-27 |
Janssen Biotech Inc |
Régions de liaison à un antigène dirigées contre les domaines de la fibronectine de type iii et leurs procédés d'utilisation
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
CA3070446A1
(en)
|
2017-07-25 |
2019-01-31 |
Immutics, Inc. |
Treating cancer by blocking the interaction of tim-3 and its ligand
|
|
DK3672631T5
(da)
|
2017-08-22 |
2024-08-26 |
Biogen Ma Inc |
Farmaceutiske sammensætninger indeholdende anti-beta-amyloid-antistoffer
|
|
TW202003576A
(zh)
*
|
2018-05-10 |
2020-01-16 |
美商艾博視訊有限公司 |
活化cd40之單株抗體及其用途
|
|
CA3100896C
(en)
*
|
2018-05-30 |
2023-08-29 |
National Health Research Institutes |
Anti-abeta antibodies and uses thereof
|
|
WO2019241685A1
(en)
|
2018-06-14 |
2019-12-19 |
Bluebird Bio, Inc. |
Cd79a chimeric antigen receptors
|
|
WO2020016661A2
(en)
*
|
2018-07-09 |
2020-01-23 |
Multitude Inc. |
Antibodies specific to folate receptor alpha
|
|
JP7654548B2
(ja)
|
2018-09-17 |
2025-04-01 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
抗ｋｌｒｇ１抗体
|
|
JP2022523502A
(ja)
*
|
2019-01-29 |
2022-04-25 |
シャンハイ ジャオ トン ユニバーシティ |
キメラ抗原受容体およびその使用
|
|
EP3918323A4
(en)
|
2019-01-30 |
2022-12-28 |
TrueBinding, Inc. |
ANTI-GAL3 ANTIBODIES AND USES THEREOF
|
|
WO2020180706A1
(en)
*
|
2019-03-02 |
2020-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapeutic antigen binding proteins specific for cd93 and methods of use thereof
|
|
KR20210143858A
(ko)
|
2019-03-26 |
2021-11-29 |
얀센 파마슈티카 엔.브이. |
피로글루타메이트 아밀로이드-β에 대한 항체 및 이의 용도
|
|
CN110343180B
(zh)
*
|
2019-07-25 |
2021-03-30 |
北京免疫方舟医药科技有限公司 |
抗ctla-4抗体及其应用
|
|
WO2021055670A1
(en)
|
2019-09-20 |
2021-03-25 |
Avx Corporation |
Somatic cell-based electrical biosensor
|
|
CN111808191A
(zh)
*
|
2020-05-11 |
2020-10-23 |
廊坊天光生物技术有限公司 |
一种用于检测血清中vegf含量的抗体对及其用途
|
|
CN111793136A
(zh)
*
|
2020-05-11 |
2020-10-20 |
廊坊天光生物技术有限公司 |
一种nmp22抗体对及其应用
|
|
US20230340089A1
(en)
*
|
2020-05-14 |
2023-10-26 |
City Of Hope |
Smc1a antibodies and uses thereof
|
|
CA3185040A1
(en)
|
2020-05-26 |
2021-12-02 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking galectin-3
|
|
KR20230019152A
(ko)
|
2020-06-02 |
2023-02-07 |
아르커스 바이오사이언시즈 인코포레이티드 |
Tigit에 대한 항체
|
|
IL299292A
(en)
|
2020-06-25 |
2023-02-01 |
Merck Sharp & Dohme Llc |
High-affinity antibodies to tau phosphorylated at serine 413
|
|
CN116348487A
(zh)
|
2020-07-23 |
2023-06-27 |
欧萨尔普罗席纳有限公司 |
抗淀粉样β抗体
|
|
EP4192501A1
(en)
*
|
2020-08-04 |
2023-06-14 |
Exelixis, Inc. |
Cd47 binding agents and uses thereof
|
|
WO2022040149A1
(en)
|
2020-08-18 |
2022-02-24 |
Omeros Corporation |
Monoclonal antibodies, compositions and methods for detecting complement factor d
|
|
CN112778419A
(zh)
*
|
2021-02-01 |
2021-05-11 |
重庆中元汇吉生物技术有限公司 |
抗ck-mb的抗体或其抗原结合部分及其应用
|
|
WO2022174103A2
(en)
*
|
2021-02-11 |
2022-08-18 |
The Regents Of The University Of California |
Monoclonal antibodies specific for human ror1
|
|
CN113075398A
(zh)
*
|
2021-03-23 |
2021-07-06 |
中国医学科学院输血研究所 |
一种血浆中特异性IgG抗体的定量测定方法
|
|
WO2023076926A1
(en)
*
|
2021-10-26 |
2023-05-04 |
Bach Diagnostics Inc. |
Lateral flow assay for the diagnosis of dermatmycoses
|
|
KR20250102074A
(ko)
*
|
2022-11-08 |
2025-07-04 |
페인스 테라퓨틱스 인코포레이티드 |
항-5t4 항체 및 이의 용도
|
|
US12534540B2
(en)
*
|
2023-01-23 |
2026-01-27 |
Clemson University Research Foundation |
CYP1A1-targeted monoclonal antibody with reactivity across vertebrate taxa
|
|
WO2024159174A1
(en)
*
|
2023-01-27 |
2024-08-02 |
The United States Goverment As Represented By The Department Of Veterans Affairs |
Compositions for treating tauopathies and methods of use thereof
|
|
EP4673476A1
(en)
*
|
2023-02-28 |
2026-01-07 |
Mayo Foundation for Medical Education and Research |
Molecules that bind to b-cell activating factor receptor polypeptides
|
|
CN119306826B
(zh)
*
|
2023-07-11 |
2025-06-20 |
东莞市朋志生物科技有限公司 |
抗白介素-6抗体、检测白介素-6的试剂和试剂盒
|
|
WO2025044931A1
(zh)
*
|
2023-08-25 |
2025-03-06 |
康诺亚生物医药科技（成都）有限公司 |
阿尔茨海默病治疗剂的开发和应用
|
|
CN119613538B
(zh)
*
|
2024-12-12 |
2025-10-17 |
浙江大学医学院附属第一医院(浙江省第一医院) |
抗h10亚型流感病毒血凝素蛋白中和性单克隆抗体1e10及其应用
|
|
CN120209138B
(zh)
*
|
2025-05-29 |
2025-10-03 |
杭州广科安德生物科技有限公司 |
Tff3、osm蛋白的抗体及其组合和在结直肠癌诊断中的应用
|